ArticleCancer science2024

Initial AXL and MCL-1 inhibition contributes to abolishing lazertinib tolerance in EGFR-mutant lung cancer cells.

Yohei Matsui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.